【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in incidence of cancer across the globe
3.5.1.2. Increase in government expenditure on healthcare
3.5.1.3. Surge in awareness regarding immunotherapy
3.5.2. Restraints
3.5.2.1. High cost of cancer immunotherapy treatment
3.5.2.2. Stringent government regulations toward approval of immunotherapy
3.5.3. Opportunity
3.5.3.1. Surge in R&D activities toward the development of immunotherapy
3.6. Government regulatory scenerio
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.6.4. Thailand
3.6.5. Singapore
3.6.6. Malaysia
3.6.7. Mexico
3.6.8. Australia
CHAPTER 4: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY THERAPEUTICS
4.1. Overview
4.1.1. Market and forecast
4.2. Natural killer cell therapies
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.3.1. CNDO-109
4.2.3.2. oNKord
4.2.3.3. Natural Killer Cells
4.2.3.4. Others
4.3. NK cell-directed antibodies
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.3.1. MOGAMULIZUMAB
4.3.3.2. Lirilumab
4.3.3.3. AFM13
4.3.3.4. NKTT 120
4.3.3.5. Others
CHAPTER 5: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by region
5.2. Cancer
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Gastrointestinal diseases
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Immunoproliferative disorders
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY END USER
6.1. Overview
6.1.1. Market and forecast
6.2. Research centers and institutes
6.2.1. Market and forecast, by region
6.2.2. Market analysis, by country
6.3. Hospitals and clinics
6.3.1. Market and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: NATURAL KILLER CELL THERAPEUTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by therapeutics
7.2.3. Market size and forecast, by application
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by therapeutics
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by therapeutics
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by end user
7.2.5.7. Mexico market size and forecast, by therapeutics
7.2.5.8. Mexico market size and forecast, by application
7.2.5.9. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by therapeutics
7.3.3. Market size and forecast, by application
7.3.4. Market size and forecast, by end user
7.3.5. Market size and forecast, by country
7.3.5.1. UK market size and forecast, by therapeutics
7.3.5.2. UK market size and forecast, by application
7.3.5.3. UK market size and forecast, by end user
7.3.5.4. Germany market size and forecast, by therapeutics
7.3.5.5. Germany market size and forecast, by application
7.3.5.6. Germany market size and forecast, by end user
7.3.5.7. France market size and forecast, by therapeutics
7.3.5.8. France market size and forecast, by application
7.3.5.9. France market size and forecast, by end user
7.3.5.10. Italy market size and forecast, by therapeutics
7.3.5.11. Italy market size and forecast, by application
7.3.5.12. Italy market size and forecast, by end user
7.3.5.13. Spain market size and forecast, by therapeutics
7.3.5.14. Spain market size and forecast, by application
7.3.5.15. Spain market size and forecast, by end user
7.3.5.16. Rest of Europe market size and forecast, by therapeutics
7.3.5.17. Rest of Europe market size and forecast, by application
7.3.5.18. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by therapeutics
7.4.3. Market size and forecast, by application
7.4.4. Market size and forecast, by end user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan market size and forecast, by therapeutics
7.4.5.2. Japan market size and forecast, by application
7.4.5.3. Japan market size and forecast, by end user
7.4.5.4. China market size and forecast, by therapeutics
7.4.5.5. China market size and forecast, by application
7.4.5.6. China market size and forecast, by end user
7.4.5.7. Australia market size and forecast, by therapeutics
7.4.5.8. Australia market size and forecast, by application
7.4.5.9. Australia market size and forecast, by end user
7.4.5.10. India market size and forecast, by therapeutics
7.4.5.11. India market size and forecast, by application
7.4.5.12. India market size and forecast, by end user
7.4.5.13. Rest of Asia-Pacific market size and forecast, by therapeutics
7.4.5.14. Rest of Asia-Pacific market size and forecast, by application
7.4.5.15. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by therapeutics
7.5.3. Market size and forecast, by application
7.5.4. Market size and forecast, by end user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by therapeutics
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. Saudi Arabia market size and forecast, by therapeutics
7.5.5.5. Saudi Arabia market size and forecast, by application
7.5.5.6. Saudi Arabia market size and forecast, by end user
7.5.5.7. South Africa market size and forecast, by therapeutics
7.5.5.8. South Africa market size and forecast, by application
7.5.5.9. South Africa market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by therapeutics
7.5.5.11. Rest of LAMEA market size and forecast, by application
7.5.5.12. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. AFFIMED N.V.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. CELGENE CORPORATION
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. FATE THERAPEUTICS INC.
8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Product portfolio
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. FORTRESS BIOTECH
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.5. GLYCOSTEM THERAPEUTICS BV
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Key strategic moves and developments
8.6. INNATE PHARMA SA
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. NANTKWEST INC
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. NKARTA THERAPEUTICS, INC.
8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NKT THERAPEUTICS INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.10. ZIOPHARM ONCOLOGY INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
【レポート販売概要】
■ タイトル：ナチュラルキラー細胞治療法の世界市場：NK細胞療法、NK細胞向け抗体■ 英文：Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2026
■ 発行日：2019年7月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9NV088
■ 調査対象地域：グローバル
- 電気用鋼の世界市場予測（～2021）：トランス、モーター、インダクタMarketsandMarkets projects that the electrical steel market size will grow from USD 27.84 Billion in 2016 to USD 38.98 Billion by 2021, at an estimated CAGR of 7.0%. The electrical steel market is witnessing considerable growth due to advancements in technology and the high efficiency of electrical steel. The electrical steel market has immense opportunities due to the increasing demand from the p …
- BRIC（ブラジル、ロシア、インド、中国）の骨粗鬆症治療薬市場About osteoporosis Osteoporosis, or porous bone, is a disease characterised by low bone density and structural deterioration of bone tissue, leading to fragile bones. This increases the risk of fractures. Osteoporosis mainly affects women, but can also affect men. In women, bone loss occurs very rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteopor …
- ボトルドウォーター（容器入り飲料水）包装の世界市場：プラスチック、ガラスAbout Bottled Water Packaging Bottled water comes from sources including wells, springs, artesian wells, and municipal water supplies. It typically undergoes a purification process before being packaged in plastic or glass bottles. Bottled water can be categorized into mineral water, still water, flavored water, and sparkling water. Bottled water is one of the most profitable beverages in the beve …
- Ipragliflozin (Type 2 Diabetes)：市場予測と分析（～2022）Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 an …
- アクチュエータの世界市場：空気圧式アクチュエータ、油圧式アクチュエータ、電気式アクチュエータ、機械式アクチュエータThe actuators market is projected to grow from USD 36.63 Billion in 2016 to USD 47.72 Billion by 2021, growing at a CAGR of 5.43% between 2016 and 2021. Factors influencing the growth of this market include rise in installation of automated systems in automotive vehicles, along with the increasing need to reduce power consumption in aircraft. The number of aircraft has increased due to rise in air …
- たばこ製造・販売企業分析：LorillardSynopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: Lorillard, including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand portfolio, as well as an assessment of compe …
- 家庭用エアコンの世界市場2015-2019About residential air conditioner A residential air conditioner is deployed to lower the air temperature of a room, maintain suitable humidity, provide ventilation, and keep the air free from dust, soot, and micro-organisms. It employs the refrigerant cycle to transport heat outside the room. The main components of the air conditioner are: • Compressor • Condenser • Metering device • Cooling coil …
- A.P. Moller – Maersk A/S：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013A.P. Moller - Maersk A/S Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary A.P. Moller - Maersk A/S Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- Petsec Energy Limited：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Petsec Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Petsec Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 世界の電力レンタル市場動向と予測(2012 – 2019)The growing demand for power, lack of grid stability and support, events (unforeseen events and planned events), tendency to rent instead of buying, and insufficient generation capacity, especially in African countries, are acting as the drivers for the power rental market. This report estimates the market value of power rental in terms of revenue ($ Million). In terms of geography, the report is …
- 世界の神経内視鏡装置市場：製品別、地域別Global Neuroendoscopy Devices Market: About this market Technavio’s neuroendoscopy devices market analysis considers sales from rigid and semi-rigid endoscopes and flexible endoscopes products. Our study also finds the sales of neuroendoscopy devices in Asia, Europe, North America, and ROW. In 2019, the rigid and semi-rigid endoscopes segment had a significant market share, and this trend is expec …
- 筋緊張性ジストロフィー(Myotonic Dystrophy)の治療薬パイプライン動向（2015年上半期版）Myotonic Dystrophy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Myotonic Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Myotonic Dystrophy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mecha …
- プロダクトスチュワードシップの世界市場予測（～2023年）Increased adoption of product stewardship solutions and services by enterprises for building their brand image is expected to drive the overall growth of the product stewardship market across the globe.The product stewardship market is projected to grow from USD 777 million in 2018 to USD 1,143 million by 2023, at a Compound Annual Growth Rate (CAGR) of 8.0% from 2018 to 2023. Growing awareness am …
- 情報技術（IT）産業年鑑2015PLUNKETT'S INFOTECH INDUSTRY ALMANAC 2015 Key Findings: • Plunkett Research lists top 500 companies in InfoTech and names top trends changing the industry for the mid term. Key Features: • Industry trends analysis, market data and competitive intelligence • Market forecasts and Industry Statistics • Industry Associations and Professional Societies List • In-Depth Profiles of hundreds of leading co …
- 尿検査製品の世界市場：ディップスティック、試薬、尿検査機器、POC検査機器、尿沈渣自動分析装置The urinalysis systems market is expected to reach $1,286 million by 2019 from $892 million in 2014, at a CAGR of 7.6%. The global urinalysis systems market is categorized on the basis of product, test type, application, end user, and region. The disease diagnostics segment is expected to register the highest growth rate in the urinalysis systems market, by application, during the forecast period. …
